Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Liezhi Wang"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionLuteolin, a natural compound commonly used in traditional Chinese medicine, shows clinical potential as an anti–liver cancer agent. The mechanisms underlying the anti–liver cancer effect of luteolin are limited versus those reported f
Externí odkaz:
https://doaj.org/article/5b24c373272b42a6aa8181e5cb0fecfe
Autor:
Weidong Lin, Kunpeng Wang, Jinggang Mo, Liezhi Wang, Zhenshun Song, Hao Jiang, Cong Wang, Chong Jin
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 14413-14425 (2023)
Abstract Background Liver cancer is a highly malignant disease and the third leading cause of cancer death worldwide. Abnormal activation of PI3K/Akt signaling is common in cancer, but whether phosphoinositide‐3‐kinase regulatory subunit 3 (PIK3R
Externí odkaz:
https://doaj.org/article/ac7a66b4be8a4cbcad441484fca8513a
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-18 (2022)
Abstract Background Hepatocellular carcinoma (HCC) is a malignant tumor with poor prognosis. N6-methyladenosine (m6A) modification has dual biological functions in RNA modification and plays an important role in HCC. Methods The GEO, TCGA, ONCOMINE,
Externí odkaz:
https://doaj.org/article/91d584efda474c8cb5abbe2737ff14e5
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Advanced hepatocellular carcinoma (HCC) is a formidable public health problem with limited curable treatment options. Axitinib, an oral tyrosine kinase inhibitor, is a potent and selective second-generation inhibitor of vascular endothelial growth fa
Externí odkaz:
https://doaj.org/article/852b2cda25ab4c1f8f6b73a1e998e195
Autor:
Jinggang Mo, Yingpeng Tong, Junxia Ma, Kunpeng Wang, Yifu Feng, Liezhi Wang, Hao Jiang, Chong Jin, Junmin Li
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction:Cyclocarya paliurus (Batal.) Iljinsk., a subtropical tree belonging to the family Juglandaceae, is rich in polysaccharides, flavonoids, and terpenoids. It has important pharmacological effects such as lowering blood lipids, blood sugar,
Externí odkaz:
https://doaj.org/article/a866c10666d3486aa3fccb888ceb4aeb
Autor:
Chunying Xiao, Sheng Liu, Ge Ge, Hao Jiang, Liezhi Wang, Qi Chen, Chong Jin, Jinggang Mo, Jin Li, Kunpeng Wang, Qianqian Zhang, Jianyu Zhou
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Hepatocellular carcinoma (HCC) is one of the most common digestive malignancies. HCC It ranges as the fifth most common cause of cancer mortality worldwide. While The prognosis of metastatic or advanced HCC is still quite poor. Recently, locoregional
Externí odkaz:
https://doaj.org/article/562cde6ef0e04b40818a68d215c9211d
Autor:
Shankun Zhao, Weizhou Wu, Hao Jiang, Lei Ma, Chengyi Pan, Chong Jin, Jinggang Mo, Liezhi Wang, Kunpeng Wang
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Advanced hepatocellular carcinoma (HCC) remains a formidable health challenge worldwide, with a 5-year survival rate of 2.4% in patients with distant metastases. The hepatocyte growth factor/cellular-mesenchymal-epithelial transition (HGF/c-Met) sign
Externí odkaz:
https://doaj.org/article/f4e0d617edab4fcba36128a345c3c5df
Autor:
Weidong Lin, Kunpeng Wang, Jinggang Mo, Liezhi Wang, Zhenshun Song, Hao Jiang, Cong Wang, Chong Jin
Publikováno v:
Cancer Medicine.
Autor:
Lin, Weidong1,2 (AUTHOR), Wang, Kunpeng2 (AUTHOR), Mo, Jinggang2 (AUTHOR), Wang, Liezhi2 (AUTHOR), Song, Zhenshun1 (AUTHOR), Jiang, Hao2 (AUTHOR), Wang, Cong3 (AUTHOR) ljgkay@163.com, Jin, Chong2 (AUTHOR) 13757689065@163.com
Publikováno v:
Cancer Medicine. Jul2023, Vol. 12 Issue 13, p14413-14425. 13p.
Autor:
Zhao, Shankun, Wu, Weizhou, Jiang, Hao, Ma, Lei, Pan, Chengyi, Jin, Chong, Mo, Jinggang, Wang, Liezhi, Wang, Kunpeng
Publikováno v:
Frontiers in Immunology; 11/2/2021, Vol. 12, p1-12, 12p